Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
Add to Evidence TrackerResearch Summary
Analyzed using Evidence Intelligence™
Online Low GI Diet Improves Diabetes Management
Last updated July 8, 2026
Key finding
HbA1c decreased from 8.33% to 7.82% (p = 0.001)
This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.
Clinical relevance
These findings highlight the potential of online dietary interventions in managing type 2 diabetes, offering a practical and accessible approach for patients to improve their health outcomes. The significant reductions in HbA1c and BMI are particularly important as they are associated with lower risks of diabetes complications.
Keep in mind
Limited generalizability due to specific participant characteristics Potential self-reporting bias in dietary adherence Short duration of the intervention may affect long-term applicability
Published in
Journal Reference
Publication details and source links for this paper.
Jinhua C, Lixia L, Xinyi Z, et al. Effectiveness of an Online Low Glycemic Index Diet and Lifestyle Intervention for Type 2 Diabetes Management: A Randomized Controlled Trial. Archives of Public Health. 2025;83:61. doi:10.1186/s13690-025-01552-0
Main Effects
HbA1c decreased from 8.33% to 7.82% (p = 0.001)
BMI decreased from 25.73 kg/m² to 24.35 kg/m² (p < 0.001)
LDL-C decreased from 2.83 mmol/L to 2.38 mmol/L (p < 0.001)
HDL-C increased from 1.21 mmol/L to 1.35 mmol/L (p = 0.001)
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Low glycemic index treatment (LGIT) and BMI, HDL cholesterol, HbA1c, and 2 more.
This study contributes evidence to
Primary intervention
Low glycemic index treatment (LGIT)
Primary outcomes
- BMI
- HDL cholesterol
- HbA1c
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
5
Evidence pairs
5
Relationships
4
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
4
Related topics
5
Evidence pairs
1608
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 5 evidence relationships
- Includes primary outcome data
- Linked to 4 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Add related evidence to your Evidence Tracker
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Glycemic Control Treatments and HbA1c
Related evidence
Evidence relationship
Glycemic Control Treatments and Body Mass Index
Save evidence
Evidence relationship
Glycemic Control Treatments and Adipokine and Angiogenic Markers
Save evidence
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
Add to Evidence TrackerHDL cholesterol
Low glycemic index treatment (LGIT) → HDL cholesterol
Low glycemic index treatment (LGIT) → HDL cholesterol
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerLDL cholesterol
Low glycemic index treatment (LGIT) → LDL cholesterol
Low glycemic index treatment (LGIT) → LDL cholesterol
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerQuality of life
Low glycemic index treatment (LGIT) → Quality of life
Low glycemic index treatment (LGIT) → Quality of life
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 25
- Negative
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- HbA1c levels significantly decreased by 0.51% (p = 0.001)
- BMI reduced by 1.38 kg/m² (p < 0.001)
- LDL-C levels decreased by 0.45 mmol/L (p < 0.001)
Who this applies to
- Adults diagnosed with type 2 diabetes
- Individuals seeking dietary interventions for diabetes management
Keep in Mind
- Results may not apply to all demographics or age groups
- Further studies needed to assess long-term effects
- Effectiveness may vary based on individual adherence to the diet
Between the Lines
- Limited generalizability due to specific participant characteristics
- Potential self-reporting bias in dietary adherence
- Short duration of the intervention may affect long-term applicability
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Glycemic Control Treatments and Body Mass Index, Glycemic Control Treatments and HbA1c.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Diet and Nutrition
Glycemic Control Treatments → Body Mass Index
Diet and Nutrition
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
View evidenceDiet and Nutrition
Glycemic Control Treatments → HbA1c
Diet and Nutrition
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 2 studies
View evidenceDiet and Nutrition
Glycemic Control Treatments → Adipokine and Angiogenic Markers
Diet and Nutrition
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceIncluded in these evidence collections
Curated evidence collections and hubs this study is part of.
Body Mass Index Evidence Hub
All studies measuring Body Mass Index
2 studies
outcome_hubMeasures Body Mass Index as a key outcome.
Glycemic Control Treatments Evidence Hub
All studies on Glycemic Control Treatments
2 studies
intervention_hubContributes to Glycemic Control Treatments evidence base.
HbA1c Evidence Hub
All studies measuring HbA1c
2 studies
outcome_hubMeasures HbA1c as a key outcome.
Adipokine and Angiogenic Markers Evidence Hub
All studies measuring Adipokine and Angiogenic Markers
1 studies
outcome_hubMeasures Adipokine and Angiogenic Markers as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Low glycemic index treatment (LGIT) and BMI
Intervention: Low glycemic index treatment (LGIT)Outcome: BMI
2 results
All studies on Low glycemic index treatment (LGIT) and HbA1c
Intervention: Low glycemic index treatment (LGIT)Outcome: HbA1c
2 results
All studies on Low glycemic index treatment (LGIT)
Intervention: Low glycemic index treatment (LGIT)
2 results
All studies measuring BMI
Outcome: BMI
2 results
All studies measuring HbA1c
Outcome: HbA1c
2 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Glycemic Control Treatments lower HbA1c?
Strong Evidence
Glycemic Control Treatments appears to lower HbA1c.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on 3 supporting studies with consistent results and a positive effect signal.
Does Glycemic Control Treatments affect body mass index?
Moderate Evidence
Glycemic Control Treatments appears to affect body mass index.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
BMI
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
Does Glycemic Control Treatments improve quality of life outcomes?
Emerging Evidence
Glycemic Control Treatments may worsen quality of life outcomes or be associated with harm.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Quality of life
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does Glycemic Control Treatments improve adipokine and angiogenic markers?
Emerging Evidence
Glycemic Control Treatments appears to improve adipokine and angiogenic markers.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HDL cholesterol
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
LDL cholesterol
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Structured exercise improves metabolic health in prediabetic adultsLow Glycemic Load Diet Improves Metabolic Profiles in Type 2 DiabetesBariatric surgery improves glucose homeostasis in type 2 diabetes.GLP-1 agonists reduce heart fat thickness in diabetes.Genetic variants linked to diabetes progression show little effect
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.